What is capsular contracture?
Capsular contracture occurs when the scar tissue capsule around a breast implant tightens. It can make the breast feel firm or hard and may cause visible distortion, asymmetry, implant displacement, tenderness, or pain.
Capsular Contracture Patient Guide
Capsular Contracture: Early Signs, Stages, Causes, and Treatment
Capsular contracture occurs when the scar tissue capsule around a breast implant tightens. It can make the breast feel firm or hard and may cause pain, visible distortion, asymmetry, or a higher implant position. Surgeons classify severity using Baker Grades I through IV. Treatment is individualized after an appropriate evaluation.
Medically reviewed by Robert Whitfield, MD, FACS on September 4, 2026
Capsular contracture happens when the scar-tissue capsule that normally forms around a breast implant tightens. Early changes can include increasing firmness, tightness, a higher implant position, asymmetry, or shape change. Clinicians describe severity using Baker Grades I through IV — patients often call these "stages." It can develop after breast augmentation or implant-based reconstruction, and the pace of change varies by patient. A new or changing breast should always be evaluated, because not every change is capsular contracture.
Understanding the Condition
What Is Capsular Contracture?
A capsule is the scar tissue that normally forms around a breast implant. Capsular contracture occurs when that capsule tightens and changes how the breast feels or looks. Symptoms can include increasing firmness, hardness, pressure, pain, visible distortion, asymmetry, or an implant that sits higher than before.
Severity is described using Baker Grades I through IV — see the full stage-by-stage table under Capsular Contracture Stages: Baker Grades I–IV below.
Clinical context: The capsule is fibrous tissue that forms around an implant, and its composition and behavior can vary among patients. Researchers are studying local immune activity and bacterial signals, but current findings do not establish a single cause of chronic inflammation or contracture in an individual patient.
Recognizing the Signs
Early Signs and Symptoms of Capsular Contracture
Capsular contracture is classified by the Baker Grade system, which describes severity based on what the patient feels and what the surgeon observes. See Capsular Contracture Stages: Baker Grades I–IV for the full table.
What Capsular Contracture Feels Like
| Symptom | Description |
|---|---|
| Firmness or hardness | The breast feels unusually firm or rock-hard, different from its natural soft texture |
| Change in breast shape | The implant rides high, sits asymmetrically, or the breast contour is distorted |
| Tightness or pressure | A sensation of squeezing or pressure around the breast and chest wall |
| Pain | Aching, burning, sharp, intermittent, or persistent pain at the implant site |
| Visible asymmetry | One breast looks or sits differently than the other |
| High-riding implant | The implant has shifted upward, creating an unnatural appearance |
Capsular contracture may become noticeable after the initial healing period or after the breast has appeared stable. Timing varies, so a new or changing breast should be evaluated rather than assessed by elapsed time alone.
Request a Capsular Contracture Surgical Evaluation
An evaluation helps clarify the symptoms, implant history, anatomy, goals, and available options. It does not mean surgery is required or that every patient is a candidate.
Timing
When Does Capsular Contracture Develop?
Timing varies by patient. Some changes become noticeable relatively soon after surgery; others appear only after the breast has looked and felt stable for a long period. A page or photograph cannot determine an individual patient's timeline, and one breast can be affected differently than the other. Because timing alone does not identify the cause, a new or changing breast — at any point after surgery — should be evaluated rather than assessed by elapsed time alone.
Postoperative Changes
Early Healing or Capsular Contracture?
The table below is educational only. It cannot diagnose normal healing or capsular contracture for any individual patient — only a clinical evaluation can do that.
| Change Noticed | Can Occur During Normal Healing | Reason to Contact the Surgical Team |
|---|---|---|
| Asymmetry | Swelling and settling can differ side to side early on | New or worsening asymmetry after the breast has settled |
| Swelling | Expected to some degree in the first weeks | Swelling that is sudden, one-sided, or does not improve |
| Breast or implant sitting higher | Implant position can evolve during postoperative healing | Contact the surgical team for a new or progressively higher position, especially when accompanied by increasing firmness, shape change, or pain |
| Increasing firmness | Mild firmness can occur during normal healing | Firmness that increases over time rather than softening |
| Worsening pain | Some discomfort is expected after surgery | Pain that worsens instead of improving, or returns after resolving |
| Rapid swelling, redness, fever, or drainage | Not expected during normal healing | Evaluate promptly — these findings are not automatically capsular contracture and may indicate another condition |
Clinical Classification
Capsular Contracture Stages: Baker Grades I–IV
Clinically these are called Baker Grades; many patients simply call them "stages." The Baker scale uses appearance, firmness, and pain to describe four clinical grades. It is useful shorthand, but it is not a laboratory test and does not identify the cause of a patient's symptoms.
| Baker Grade | How It Feels | What You May See | Pain or Discomfort | Typical Next Step |
|---|---|---|---|---|
| Grade I | Soft, like a natural breast | Natural appearance | Usually none | Routine follow-up or observation |
| Grade II | Slightly firm | Usually looks normal | Often none | Clinical review if new, changing, or concerning |
| Grade III | Firm | Visible distortion or abnormal shape | May be uncomfortable; pain is not required | Individualized surgical evaluation is commonly discussed |
| Grade IV | Hard | Clearly abnormal or distorted appearance | Painful or tender | Prompt individualized surgical evaluation |
Baker grading is a clinical assessment. It does not determine the exact operation, establish implant rupture, or replace an individualized examination.
Grade III and Grade IV findings are generally the most clinically significant because they involve visible distortion, pain, or both. Grade I and some Grade II findings may not require an operation, but a new or changing breast should be assessed in the context of the patient's history and goals.
Causes and Contributors
Risk Factors and Possible Contributors
Capsular contracture is considered multifactorial, and researchers have not identified one established cause. The FDA notes that capsular contracture may be more common following infection, hematoma (a collection of blood), or seroma (a collection of fluid) — without establishing that any single factor causes contracture in a given patient. [1] These associations do not establish the cause of contracture in an individual patient.
Prevention Limits
Can Capsular Contracture Be Prevented?
No method has been shown to guarantee prevention of capsular contracture. The FDA has not cleared or approved any device to treat or reduce the incidence of capsular contracture. [1] Because risk factors and individual healing vary, any risk-reduction steps should be discussed with your own surgeon rather than applied universally. This page does not recommend a specific massage routine, antibiotic practice, vitamin regimen, implant texture, or implant plane as a guaranteed way to reduce risk.
Diagnosis
How Capsular Contracture Is Evaluated
Evaluation begins with the patient's symptoms, timing, implant history, prior operations, and goals. A physical examination assesses firmness, tenderness, breast shape, implant position, skin and soft tissue, and differences between sides. Baker grade is assigned clinically rather than by a website quiz or photograph.
Imaging may be considered when the history or examination raises questions about implant integrity, fluid, a mass, or another condition. Ultrasound or magnetic resonance imaging can provide information about selected implant complications, but imaging does not replace the clinical Baker assessment and does not by itself prescribe an operation.
The discussion may include observation, capsulotomy, partial or total capsulectomy, implant removal without replacement, implant exchange, pocket or plane change, and breast-shape options such as lift or fat transfer. The appropriate plan depends on anatomy, symptoms, operative history, safety, preferences, and informed consent.
When to Seek Prompt Medical Evaluation
Rapid swelling, a new breast or armpit mass, marked redness, drainage, fever, sudden severe pain, or a rapid change in breast shape should be evaluated promptly. These findings are not automatically capsular contracture and may require assessment for other implant or breast conditions. [1]
Nonsurgical Options
Can Nonsurgical Treatment Reverse Capsular Contracture?
The FDA has not cleared or approved any device to treat or reduce the incidence of capsular contracture. [1] Stable, mild findings may sometimes be observed after clinical evaluation, but observation is not the same as reversing the capsule. Patients should not aggressively massage a painful or changing breast, start or stop medication, or use a device-based therapy without guidance from their own clinician. Grade III or IV findings, worsening distortion, or increasing pain commonly lead to an individualized discussion of surgical options, but they do not automatically require one specific operation.
Treatment Options
Individualized Treatment for Capsular Contracture
Grade III and Grade IV capsular contracture often prompt discussion of surgery, but no single operation is best for every patient. Options may include capsulotomy, partial or total capsulectomy, implant removal, implant exchange, pocket change, and breast-shape procedures. The plan depends on anatomy, symptoms, implant history, safety, goals, and informed consent. [4]
Published evidence is largely observational and heterogeneous. Recurrence can occur after different approaches, and current evidence does not show that complete capsulectomy is universally superior or guarantees removal of all capsule tissue, microbial material, or a proposed immune trigger.
Capsulectomy — Partial or Total Capsule Removal
Capsulectomy means surgical removal of some or all of the capsule. Partial and total procedures have different extents, and safe removal may be limited by adherence to the chest wall or other anatomy. A surgeon should explain the intended extent, alternatives, and procedure-specific risks without promising complete removal or freedom from recurrence.
Learn about all capsulectomy options →
Total Intact Capsulectomy and En Bloc Terminology
For significant capsular contracture without suspected malignancy, an attempt to remove the implant and capsule together without disrupting the capsule is generally described as a total intact capsulectomy, not an en bloc capsulectomy. The extent and technique of capsule removal are selected individually based on anatomy, operative findings, safety, symptoms, and informed consent.
Breast Surgery Collaborative Community terminology reserves en bloc capsulectomy for removal of the capsule with a margin of uninvolved tissue in patients with suspected or established breast implant-associated malignancy after appropriate medical workup. Intact removal cannot always be performed safely, and no technique guarantees complete removal, symptom resolution, or freedom from recurrence. [8]
Review capsulectomy terminology and indications →
Volume Restoration After Removal
Some patients who undergo explant choose fat transfer breast augmentation. No implant capsule forms when no implant remains. Fat retention is variable, however, and recognized risks include resorption, fat necrosis, oil cysts, calcification, infection, contour irregularity, and possible staged procedures. Retained fat may behave like other body fat, but there is no permanence guarantee.
Can Capsular Contracture Return After Treatment?
Capsular contracture can recur when an implant remains or a new implant is placed. Published recurrence estimates vary widely because studies differ in Baker grade, primary versus revision surgery, implant plane and type, procedure, follow-up duration, and patient selection. A systematic review found limited high-level evidence for choosing one management strategy for every patient. [4]
Recurrence risk should be discussed for the specific plan under consideration. Implant exchange, capsulotomy, partial or total capsulectomy, plane change, acellular dermal matrix, implant removal without replacement, and reconstructive choices each involve different tradeoffs. No approach guarantees that contracture, pain, or another complication will not occur.
The Underlying Mechanism
Why Capsular Contracture Develops
Capsular contracture is considered multifactorial and is not fully understood. Proposed contributors include the wound-healing response, implant and surgical factors, bleeding, inflammation, and microbial signals. Biofilm is one hypothesis under study, but current evidence does not establish it as the cause in an individual patient.
What Is Bacterial Biofilm?
A biofilm is a structured microbial community within a matrix. Biofilms can occur on medical devices, and investigators have studied whether they may contribute to some breast-implant complications. DNA detection alone does not demonstrate a mature biofilm, viable organisms, or infection.
Laboratory methods answer different questions: culture assesses growth under specified conditions, molecular assays detect targeted nucleic-acid material, and microscopy or other methods may evaluate structure. None of these findings, by itself, proves why a particular capsule hardened or what treatment that patient needs.
Bacteremia and Breast Implants
Bacteremia means viable bacteria are present in the bloodstream. It may be transient and asymptomatic, but it can also accompany or progress to a bloodstream infection. Transient bacteremia can occur with oral hygiene, dental or medical procedures, and some infections; its clinical significance varies by context. [7]
Hematogenous seeding has been proposed as one possible route by which microorganisms could reach an implant, but human evidence does not establish that routine transient bacteremia causes late capsular contracture. Guidance about antibiotic prophylaxis for selected cardiac conditions should not be extrapolated to breast implants. Patients should follow their own clinicians' dental and medical recommendations rather than taking antibiotics for an unproven implant indication.
Evidence-Based Insights
The Research: What PCR Testing Reveals Inside Capsules
Dr. Whitfield published a retrospective analysis of 694 submitted capsule and associated tissue specimens. Of these, 203 of 694 submitted capsule or associated tissue specimens (29%) returned positive molecular findings under the study method, which reported 103 taxa labels. These molecular findings require clinical context. [5]
| Research Metric | Finding |
|---|---|
| Total specimens analyzed | 694 submitted capsule and associated tissue specimens |
| Testing method | Endpoint PCR screening followed by targeted next-generation sequencing of 16S rRNA V1–V2 and ITS3–4 targets, with a multispecies qPCR panel |
| Submitted capsule or associated tissue specimens with positive molecular findings under the study method | 203 of 694 (29%) |
| Reported taxa labels | 103 taxa labels, with lineage resolution limited by the assay and reference data |
| Paired conventional-culture comparison | Not performed on all 694 submitted specimens; no all-specimen sensitivity comparison can be inferred |
| Publication | Microorganisms, September 2024, Vol. 12(9):1830 |
| Status | Published retrospective submitted-specimen series |
Research interpretation: Optional PCR and targeted sequencing may report bacterial DNA fragments and related classifications. Those findings do not establish viability, infection, colonization, contamination, biofilm behavior, immune effect, or symptom causation. They also do not establish species presence where the assay cannot resolve lineage.
The results describe assay classifications in a retrospective submitted-specimen series, not a prevalence estimate for all implant capsules. A detected taxonomic label may generate a research hypothesis, but it cannot show whether an organism was alive, where the detected material originated, or whether it affected that patient's capsule or symptoms.
What this means for patients: Molecular findings cannot diagnose infection or assign a cause of capsular contracture. History, examination, imaging when indicated, operative findings, pathology, and microbiology must be interpreted together.
Individual Variability
Why Two Women with Identical Implants Have Different Outcomes
This is the question capsular contracture research has struggled to answer for decades. Two women can receive the same implant from the same manufacturer, placed by the same surgeon using the same technique — and one develops severe contracture within two years while the other has soft, comfortable implants a decade later.
Tissue-level molecular research is one area being explored, but it does not provide one established explanation for why contracture develops in a particular patient.
The 2025 Transcriptome Finding
A 2025 study published in Plastic and Reconstructive Surgery used whole-transcriptome RNA sequencing to compare gene-expression patterns in capsule tissue with and without capsular contracture. The assay denominator was 51 breasts from 50 women; the analysis reported 1,500 differentially expressed genes, including 873 upregulated and 627 downregulated genes. This transcriptome association is hypothesis-generating and does not establish causation, diagnose an individual patient, measure biofilm burden, or direct treatment. [6]
| Finding | Data |
|---|---|
| Total differentially expressed genes | 1,500 |
| Genes upregulated in capsular contracture | 873 |
| Genes downregulated | 627 |
| Immune pathways activated | T cell, B cell, and plasma cell activation — pathways associated with organ allograft rejection |
The authors reported enrichment of gene-expression pathways that are also labeled in transplant-rejection research. Shared pathway labels do not mean that a breast implant is being rejected like a transplanted organ, and they do not establish a treatment directive.
What This Does NOT Mean
These are similarities in gene-expression pathway labels, not evidence of true allograft rejection.
A breast implant is not transplanted donor tissue. The study's pathway findings should not be interpreted as literal transplant rejection, an individual diagnosis, or a treatment directive.
What the Study Can Support
The study supports an association between capsular contracture and different gene-expression patterns in the sampled tissue. It does not establish that bacteria or biofilm caused those patterns, and it did not measure bacteremia, symptom severity, response to conservative care, or recurrence.
These group-level findings cannot explain why a particular patient develops Grade IV disease. Individual variation remains an area of research within a multifactorial condition.
Expert Care
Dr. Whitfield's Approach to Capsular Contracture
Dr. Whitfield may submit removed capsule or associated tissue for pathology and optional molecular testing when clinically appropriate. Endpoint PCR, targeted sequencing, and qPCR can detect selected nucleic-acid targets, subject to sampling, assay, lineage-resolution, and reference-database limits.
A molecular result does not establish viability, infection, colonization, contamination, biofilm behavior, immune effect, or symptom causation in a specific patient. Results are considered with the clinical history, examination, operative findings, pathology, and other testing rather than used as a stand-alone diagnosis or treatment directive.
| Dr. Whitfield's Approach | Detail |
|---|---|
| Capsule removal technique | Extent and technique selected individually; en bloc terminology reserved for suspected or established implant-associated malignancy |
| Specimen testing | Pathology and optional molecular testing considered in clinical context |
| Research foundation | Retrospective series: 203 of 694 submitted capsule or associated tissue specimens (29%) returned positive molecular findings under the study method; 103 taxa labels |
| Implant exchange for contracture | Discussed individually with recurrence uncertainty, alternatives, and tradeoffs |
| Combined procedures | Capsulectomy and fat transfer breast augmentation may be performed together in one surgery for appropriately selected patients after individualized evaluation |
Patient Questions
Frequently Asked Questions About Capsular Contracture
What does capsular contracture feel like?
Patients may notice increasing firmness, tightness, pressure, tenderness, pain, or a breast that feels different from the other side. The implant may also appear higher, rounder, or visibly distorted.
Which Baker grade is painful?
Baker Grade IV is defined by a hard, painful breast with an abnormal appearance. Grade III has visible distortion and may be uncomfortable, but pain is not required for the Grade III classification.
Can capsular contracture be left untreated?
Mild findings may be observed when they are stable and not troubling the patient. Increasing firmness, pain, distortion, a change in implant position, or uncertainty about the cause should be evaluated by a qualified clinician.
How quickly does capsular contracture progress?
Progression varies. Changes may develop over months or years, remain stable, or become more noticeable. A page or photograph cannot determine an individual patient's progression, so new or worsening findings deserve clinical assessment.
Can massage or home treatment reverse capsular contracture?
Home treatment should not substitute for clinical evaluation. Patients should not aggressively massage a painful or changing breast or start a treatment without guidance from their own clinician.
Can capsular contracture return after treatment?
Yes. Recurrence has been reported after different treatments. The risk depends on the operation, whether an implant remains or is replaced, the surgical setting, anatomy, healing, follow-up time, and other individual factors.
Does insurance cover capsular contracture treatment?
Coverage varies by plan, implant history, symptoms, reconstruction status, and the reason for surgery. The practice can provide clinical documentation when appropriate, but the patient should confirm benefits and authorization requirements directly with the insurer.
Is capsular contracture dangerous?
Capsular contracture ranges from mild firmness to painful, visible distortion. The urgency of evaluation depends on the symptoms and how quickly they are changing. Rapid swelling, a new breast or armpit mass, marked redness, drainage, fever, sudden severe pain, or a rapid change in breast shape should be evaluated promptly. These findings are not automatically capsular contracture and may represent another breast or implant condition requiring timely care.
Can capsular contracture happen after breast augmentation and reconstruction?
Yes. Capsular contracture can occur around implants placed for cosmetic breast augmentation or implant-based breast reconstruction. Evaluation and treatment may differ based on the original operation, implant history, symptoms, anatomy, implant condition, reconstructive goals, and informed patient preferences.
Evidence and Review
Medical References
This page uses FDA patient-safety information, professional-society education, peer-reviewed evidence, and Dr. Whitfield's published capsule research. References support general education and do not replace individualized medical advice.
- U.S. Food and Drug Administration. Risks and Complications of Breast Implants.
- U.S. Food and Drug Administration. Breast Implants. General FDA patient-safety and regulatory information.
- American Society of Plastic Surgeons. Here's what you need to know about capsular contracture.
- Boyd CJ, Chiodo MV, Lisiecki JL, Wagner RD, Rohrich RJ. Systematic Review of Capsular Contracture Management following Breast Augmentation: An Update. Plastic and Reconstructive Surgery. 2024.
- Whitfield RM, Tipton CD, et al. Clinical Evaluation of Microbial Communities and Associated Biofilms with Breast Augmentation Failure. Microorganisms. 2024;12(9):1830.
- Larsen A, et al. Transcriptome of Capsular Contracture around Breast Implants Mimics Allograft Rejection: A Matched Case-Control Study. Plastic and Reconstructive Surgery. 2025;156:59e–72e.
- National Center for Biotechnology Information. Bacteremia. StatPearls.
- Breast Surgery Collaborative Community. Consensus Statement on Breast Implant Capsulectomy Definitions and Management.
About the Physician Reviewer
Dr. Whitfield is a board-certified plastic surgeon in Austin, Texas. His clinical focus includes breast implant removal, capsulectomy, revision breast surgery, and fat-transfer options. He is an author of the cited 2024 submitted-specimen capsule series. Research findings are presented with their limitations and are not used as a stand-alone diagnosis or treatment directive.
Medically reviewed by Robert Whitfield, MD, FACS on September 4, 2026
Austin and Out-of-Town Patients
Get an Individualized Review of Pain, Firmness, Distortion, or Recurrent Contracture
Dr. Whitfield evaluates implant history, prior operations, symptoms, breast anatomy, imaging when indicated, and personal goals. The evaluation is a clinical and surgical planning visit, not an online diagnostic test and not a promise that surgery will be recommended.
Confidential evaluations are available for patients in Austin and for patients planning travel to Texas.
Closer to home? See capsular contracture care in Austin or across Texas.